KENNETH MCCLAIN to Immunosuppressive Agents
This is a "connection" page, showing publications KENNETH MCCLAIN has written about Immunosuppressive Agents.
Connection Strength
0.466
-
A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer. 2007 Jan; 48(1):44-9.
Score: 0.191
-
Drug therapy for the treatment of Langerhans cell histiocytosis. Expert Opin Pharmacother. 2005 Nov; 6(14):2435-41.
Score: 0.176
-
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013 Jun 20; 121(25):5006-14.
Score: 0.074
-
A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017 Sep 01; 123(17):3229-3240.
Score: 0.025